FDA 483 Database
FDA Form 483s Issued in July 2022
Every published Form FDA 483 issued in July 2022, drawn from the FDA OII FOIA Electronic Reading Room. Each row links to the FDA source record.
4
Published 483s in July 2022
4
Distinct firms
Form 483s issued in July 2022
Revance Therapeutics, Inc.FDA
- FEI
- 3007772056
- Issued
- Jul 15, 2022
- Establishment
- Active Pharmaceutical Ingredient & Finished Dosage Manufacturer
- Location
- United States
Valisure, LLCFDA
- FEI
- 3012063246
- Issued
- Jul 6, 2022
- Establishment
- Bioanalytical Lab
- Location
- Connecticut, United States
AnazaoHealth CorporationFDA
- FEI
- 3011152407
- Issued
- Jul 29, 2022
- Establishment
- Outsourcing Facility
- Location
- Nevada, United States
Cipla LimitedFDA
- FEI
- 3008581988
- Issued
- Jul 1, 2022
- Establishment
- Finished Pharmaceutical Manufacturer
- Location
- India
| Company | FEI | Establishment type | Location | Issued | Source |
|---|---|---|---|---|---|
| Revance Therapeutics, Inc. | 3007772056 | Active Pharmaceutical Ingredient & Finished Dosage Manufacturer | United States | Jul 15, 2022 | FDA |
| Valisure, LLC | 3012063246 | Bioanalytical Lab | Connecticut, United States | Jul 6, 2022 | FDA |
| AnazaoHealth Corporation | 3011152407 | Outsourcing Facility | Nevada, United States | Jul 29, 2022 | FDA |
| Cipla Limited | 3008581988 | Finished Pharmaceutical Manufacturer | India | Jul 1, 2022 | FDA |